ロード中...
Saxagliptin: A dipeptidyl peptidase-4 inhibitor in the treatment of type 2 diabetes mellitus
Type 2 diabetes mellitus (T2DM) is a metabolic disorder characterized by insulin deficiency or resistance. Management starts with single oral antidiabetic drug (OAD) but eventually switch over to combination therapy because of progressive β-cell dysfunction. Hypoglycemia, weight gain, and adverse ca...
保存先:
| 第一著者: | |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Medknow Publications Pvt Ltd
2011
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3198516/ https://ncbi.nlm.nih.gov/pubmed/22025849 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0976-500X.85934 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|